Oncology
Advertisement
A study has uncovered a novel method to enhance immunotherapy for melanoma by targeting a protein known as MARCO.
Researchers assessed ICD gene expressions to predict immunotherapy response and immune cell infiltration.
Dr. John Fruehauf details how novel therapies have improved the landscape of metastatic melanoma care.
Researchers aimed to evaluate the roll of ERCC1 expression in predicting response to adjuvant chemotherapy for TNBC.
Dr. Amin Mirhadi details the benefits and disadvantages of using proton therapy in patients with head and neck cancer.
The global burden of cervical cancer, as well as cervical cancer mortality, is predicted to increase substantially by 2030.
TILs can serve as a biomarker to identify patients with ERBB2-positive early breast cancer who can reduce adjuvant therapy.
Cancer recurrence fear appreciably impacts breast cancer survivors’ ability to re-enter the workforce.
Researchers identified 23,450 trial sites; a majority of them began before 2020.
The main features of intestinal inflammation are reproduced as a biomarker for response to immune checkpoint inhibition.
There was a 29% increase in cancer detection with AI-supported screening.
Researchers found two effective treatments for metaplastic breast cancer.
Subgroup analyses of multiple diagnostic performance metrics in high vs low-income communities were also performed.
New research has uncovered a combination therapy that shows promising results in melanoma and breast cancer models.
A study compared the screening performances of a tools used in cervical cancer screening in HIV-positive women.
Aliya Omer, AstraZeneca, talks about data that backs the efficacy of olaparib in treating high-risk early breast cancer.
Results were deduced from self-collected as well as clinician-obtained screening results.
In patients with high-risk HER2-psoitive breast cancer, adjuvant trastuzumab emtansine reduces the long-term risk of death.
A recent study shows that macrophages can be used to predict whether or not a melanoma patient will respond to chemotherapy.
The study used SEER data of nearly 20,000 cases.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.